tirzepatide in nash Tirzepatide: A Game-Changer for MASH Treatment Tirzepatide: First Approval | Drugs

Higher TTV viral load was associated with: Infection-related hospitalisations De novo malignancy These results are now published in In an exploratory analysis of patients who did not develop rejection, those with fewer eplet mismatches to their donor had lower TTV viral loads, suggesting that it may be possible to individualise TTV targets

Is it safe to taper GLP-1 therapy on my own

Retatrutide's phase 2 obesity data (around 24% at the top dose) edged tirzepatide's SURMOUNT-1 result (about 21%), but they come from different trials, not a head-to-head, and retatrutide is not approved

Aim to include at least one cup of vegetables with every meal, and stay hydrated by drinking at least 64 ounces of water daily

Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans